The Community Oncology Alliance (COA) filed an Amicus Curiae brief with the United States Court of Appeals for the Seventh Circuit warning that contract pharmacies affiliated with pharmacy benefit managers (PBMs) have taken over and mutated the 340B Drug Pricing Program. In addition to diverting 340B discounts from patients in need, lucrative for-profit PBM

Dear Chair Lina M. Khan, Commissioners, and Staff: On behalf of the Board of Directors of the Community Oncology Alliance (“COA”), we are pleased to share information on the United States Federal Trade Commission’s (“FTC”) Solicitation for Public Comments on the Business Practices of Pharmacy Benefit Managers and Their Impact on Independent Pharmacies and

Dear Administrator Brooks-LaSure:On behalf of the Board of Directors of the Community Oncology Alliance (“COA”), we are writing to request that the Centers for Medicare & Medicaid Services (“CMS”) revise the CY 2023 Medicare Advantage and Part D Proposed Rule (CMS-4192-P) (the “Proposed Rule”) being finalized to address the Pharmacy Benefits Manager (“PBM”) Express Scripts,

Dear Administrator Brooks-LaSure, The undersigned organizations, representing millions of Medicare beneficiaries with life-threatening, complex, chronic conditions and/or the physicians who care for them, are asking the Centers for Medicare and Medicaid Services (CMS) to ensure that beneficiaries enrolled in Medicare Advantage plans continue to have appropriate and timely access to the therapies they need

Dear Administrator Brooks-LaSure and Deputy Administrator Fowler: On behalf of the Board of Directors of the Community Oncology Alliance (“COA”), we are asking you to please extend the Oncology Care Model (“OCM”) past the scheduled termination date of June 30, 2022, and to announce this extension immediately.  As you know, the OCM starts winding

Dear National Government Services Medical Policy Unit, On behalf of the Community Oncology Alliance (COA), we appreciate the opportunity to submit this public comment for the Proposed LCD - Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms (DL37810). COA is an organization dedicated to advocating for the complex care and access needs

Dear Administrator Brooks-LaSure: On behalf of the Board of Directors of the Community Oncology Alliance (“COA”), we are submitting this comment letter regarding the CY 2022 Medicare Hospital Outpatient Prospective Payment System (“HOPPS”) Proposed Rule, Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs; Price Transparency of

Dear Administrator Brooks-LaSure: On behalf of the Board of Directors of the Community Oncology Alliance (“COA”), we are submitting this comment letter regarding the CY 2022 Medicare Physician Fee Schedule Proposed Rule (“MPFS”, “the Proposed Rule”). As you know, COA is an organization dedicated to advocating for the complex care and access needs of

Dear Majority Leader Schumer, Minority Leader McConnell, Speaker Pelosi, and Minority Leader McCarthy: On behalf of the Board of Directors of the Community Oncology Alliance (“COA”), we are writing to ask that you please help address the unfolding cancer care “infrastructure” crisis in this country and not make it worse with destructive policy and